Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02427 |
| Species: | Homo sapiens |
| Position : | chr6:135321297-135321697 |
| Year: | 2019 |
| Title: | Global Analysis of Enhancer Targets Reveals Convergent Enhancer-Driven Regulatory Modules. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 31775028 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K-562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay; Disease-variant functional analysis |
| High Throughput Method: | scRNA-seq, RNA-seq, Hi-C, ChIP-seq |
| Low Throughput Method: | CRISPRi, RT-RT-qPCR |
| Target gene : | MYB |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02442 | chr6:135321297-135321697 | blood | malignant cell | NA |